Launching a new chapter in cancer immunotherapy field, scientists have blended two cutting-edge approaches: CRISPR and T cell therapy.

Science

Launching a new chapter in the fast-moving cancer immunotherapy field, scientists have blended two cutting-edge approaches: CRISPR and T cell therapy.

The gravely ill patients received altered versions of their own immune cells in an early test

SCIENCEMAG.ORG

Cutting-edge CRISPR gene editing appears safe in three cancer patients

The gravely ill patients received altered versions of their own immune cells in an early test